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Magnetic nanoparticles (MNPs), especially iron oxide nanoparticles, have attracted 
much attention in the last decades due to their remarkable physicochemical and magnetic 
properties. These properties coupled with their low toxicological effects, make MNPs ideal 
for biomedical applications1. In addition, chemical functionalization with specific 
biocompatible targeting molecules provides them with the ability to selectively attach to cells 
or tissues. Thus, MNPs can be simultaneously used in both diagnosis and therapy, i. e. as 
contrast agents for magnetic resonance imaging (MRI) and as nanoheaters in magnetic 
hyperthermia based therapy2. MNPs are known to enhance the contrast of the clinical MR 
images. On the other hand, magnetic hyperthermia is a promising cancer therapy relying on 
the use of the unique magnetic properties of MNPs to generate heat under an alternating 
magnetic field. The increase of temperature selectively destroys the tumour cells, inherently 
more sensitive to mild-temperature changes (of 5 to 7 ºC above the body temperature), while 
preserving the healthy ones3. Nevertheless, the poor heating efficiency of most reported 
MNPs, together with the lack of biocompatibility studies, hampers the spread of 
multifunctional nanoparticles as the next generation of therapeutic bio-agents in medicine. 
Hence, in this study, two different sets of iron oxide nanoparticles were synthesized by co-
precipitation, modifying the synthesis temperature (30 and 55 ºC) at moderate alkaline pH (ca. 
9). These mild conditions allow the production of superparamagnetic nanoparticles through a 
cost efficient and industry friendly scalable procedure. The synthesized materials proved to be 
suitable for theranostic applications. In addition, a novel haemocompatibility methodology 
based in a microfluidic device that mimics the haemodynamic behaviour of blood cells in in 
vitro microvascular environment was used with noteworthy results.  
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